Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Sanjay Adhikary

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

Unknown Researcher

2 h-index 9 pubs 12 cited

  • Verbena
  • Acetone
  • Butanols
  • Animals
  • Chloroform
  • Hexanes
  • Plant Extracts
  • Triterpenes
  • Mice

Biography and Research Information

OverviewAI-generated summary

Sanjay Adhikary's research focuses on the investigation of potential therapeutic agents, particularly in the context of melanoma treatment. His work includes exploring the antimicrobial properties of plant extracts, such as those from Verbena officinalis. Adhikary has also synthesized and studied novel thiazole-fused bisnoralcohol derivatives and thiazole-fused androstenone and ethisterone derivatives, identifying them as potent inhibitors of the β- and γ-actin cytoskeleton, which may be relevant for treating melanoma tumors. His recent publications also touch upon the role of ATF6 activation in promoting immune checkpoint blockade (ICB) response in melanoma. Adhikary has collaborated with researchers from Arkansas State University and the University of Arkansas for Medical Sciences on multiple publications. His scholarship metrics include an h-index of 2, with 9 total publications and 12 total citations.

Metrics

  • h-index: 2
  • Publications: 9
  • Citations: 12

Selected Publications

  • Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy (2026)
    Cancer Research DOI OpenAlex
  • 691 ATF6 activation promotes ICB response in melanoma (2025)
    Regular and Young Investigator Award Abstracts DOI OpenAlex
  • Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2025)
    RSC Medicinal Chemistry DOI OpenAlex
  • Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2024)
    RSC Medicinal Chemistry 1 citation DOI OpenAlex
  • Efficient Synthesis of Thiazole-Fused Bisnoralcohol Derivatives as Potential Therapeutic Agents (2024)
    ACS Omega 4 citations DOI OpenAlex
  • In Vitro Antimelanoma Properties of Verbena officinalis Fractions (2022)
    Molecules 7 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

21 Collaborators 6 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics